High-doses of proton pumps inhibitors in refractory gastro-intestinal cancer: A case series and the state of art

In recent years, proton pump inhibitors (PPIs) have been investigated at high-dose to modulate tumour microenvironment acidification thus restoring chemotherapeutic sensitivity. Moreover, several clinical data supports the role of cytotoxic drugs at low-dose continuously delivered as anticancer therapy.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2d9ogyz
via IFTTT